Mikhail Blagosklonny is a scientist who is currently working for Roswell Park Cancer Institute. Mikhail has been serving in this institution for a while now, and he is believed to have introduced several changes. The institute is based in Buffalo, New York City.While working in the organization, Mikhail has been in charge of several research projects, especially those concerning cancer and aging. Apart from being a professor of oncology at the well-known institution, Mikhail is the chief editor for one of the most popular scientific journals in the United States, known as Oncotarget. While serving in this position, the scientist has done a lot to help people to understand cancer and its treatments. Under his leadership, the successful journal has published several cancer studies, and they have assisted very many individuals in the world.
Mikhail Blagosklonny has been instrumental in the invention of a drug known as Rapamycin. The medical drug is also called Sirolimus, and it is mostly used by medical professionals in the world to prevent any organ transplant rejection by the human body. In the past, the drug has also been used to treat coronary stents and several lung diseases. In the market, the drug is called Rapamune. Some people say that the drug helped them to cure several types of cancer. According to Mikhail Blagosklonny, the cancer drug was first discovered in the year 1972 on Easter Island. The people who discovered it used it as a very effective anti-fungal agent. Later on, medical professionals realized that the drug had wonderful antiproliferative properties and immunosuppressive features. When medical professionals made this discovery, they chose to abandon the use of the great medical drug as an anti-fungal agent. While serving at the Roswell Park Cancer Institute, Mikhail has been a staunch supporter for the use of Rapamycin. The scientist says that the drug is very effective for the treatment of cancer and increasing the lifespan of humans.
According to Blagosklonny, individuals who use the drug tend to live longer when compared to the ones who do not.For the individuals living with the hemolytic –uremic syndrome, a great medical professionals say that they are likely to get the help they have been searching when they use Rapamycin. The medical condition is very rare, and it is mostly caused by kidney failure, anemia and low platelet count in the body. When a patient has this condition, they get a major renal failure, and they do not get the treatment they need in a short time, they get serious problems. These patients are sometimes forced to undergo a permanent dialysis so that they might prolong their lives. If you are suffering from this condition, the only permanent solution is getting kidney transplantation. Sometimes, the new kidney can contract the same disease, and this is why most patients will be advised to use Rapamycin. According to Mikhail Blagosklonny, the drug has very little toxicity to the human kidneys, and it is the best remedy to kidney transplant patients. Mikhail says that the people using the drug have a high probability of living a better life.